Boston's resTORbio Sets Terms for $85M IPO Post author:Sam Post published:January 16, 2018 Post category:BioPharma resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace You Might Also Like Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017 North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray December 21, 2017 Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations August 31, 2017
Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017
North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray December 21, 2017
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations August 31, 2017
